13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001600004
Total reported value
$1.6B
$1.6B
44 檔
16.3%
At the close of Q2 2024, First Light Asset Management, LLC disclosed equity holdings valued at approximately $1.6B, spread across 44 reported holdings.
During Q2 2024, First Light Asset Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FNAUSD | Paragon 28 Inc | Stock-Other | 4.90% | — | +114.96% | |
| 2 | ATEC | Alphatec Holdings Inc | Stock-Other | 4.88% | — | -1.67% | |
| 3 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 4.71% | -0.45% | -28.97% | |
| 4 | NEO | Neogenomics Inc | Stock-Healthcare | 4.60% | +4.42% | +14.55% | |
| 5 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 4.46% | — | -1.05% | |
| 6 | TMDX | Transmedics Group Inc | Stock-Healthcare | 3.97% | — | -57.76% | |
| 7 | ATRC | Atricure Inc | Stock-Other | 3.92% | -0.90% | +42.08% | |
| 8 | PODD | Insulet CORP | Stock-Healthcare | 3.81% | — | +42.56% | |
| 9 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 3.78% | -5.56% | EXIT | |
| 10 | NTRA | Natera Inc | Stock-Healthcare | 3.50% | — | -43.80% | |
| 11 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 3.47% | — | +21.85% | |
| 12 | LIVN | LivaNova PLC | Stock-Other | 3.41% | — | +591.09% | |
| 13 | INSM | Insmed Inc | Stock-Healthcare | 3.24% | — | +94.97% | |
| 14 | PLRX | Pliant Therapeutics Inc | Stock-Other | 3.21% | — | -3.78% | |
| 15 | VERA | Vera Therapeutics Inc | Stock-Other | 3.19% | -1.13% | EXIT | |
| 16 | SIBN | Si-bone Inc | Stock-Other | 2.80% | +2.00% | +0.01% | |
| 17 | RCM1USD | R1 Rcm Inc | Stock-Other | 2.71% | — | -3.43% | |
| 18 | PFMTUSD | Performant Financial CORP | Stock-Other | 2.67% | — | -0.01% | |
| 19 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 2.59% | — | -11.25% | |
| 20 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 2.50% | +0.84% | +49.13% | |
| 21 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 2.46% | — | +16.07% | |
| 22 | EVH | Evolent Health Inc - A | Stock-Other | 2.42% | — | +401.53% | |
| 23 | HCAT | Health Catalyst Inc | Stock-Other | 2.22% | +0.08% | +438.48% | |
| 24 | AXGN | Axogen Inc | Stock-Other | 2.12% | -4.16% | +336.62% | |
| 25 | GPCR | Structure Therapeutics Inc | Stock-Other | 2.03% | — | +296.11% | |
| 26 | NARIUSD | Inari Medical Inc | Stock-Other | 1.99% | — | +120.80% | |
| 27 | ANAB | Anaptysbio Inc | Stock-Other | 1.71% | -0.42% | -17.47% | |
| 28 | OPRX | Optimizerx CORP | Stock-Other | 1.60% | — | +5.14% | |
| 29 | TCMD | Tactile Systems Technology I | Stock-Other | 1.40% | +0.84% | NEW | |
| 30 | DYN | Dyne Therapeutics Inc | Stock-Other | 1.18% | — | +260.96% | |
| 31 | KRMD | Koru Medical Systems Inc | Stock-Other | 1.17% | -0.60% | -3.50% | |
| 32 | AVTR | Avantor Inc | Stock-Healthcare | 1.11% | — | -29.93% | |
| 33 | GH | Guardant Health Inc | Stock-Healthcare | 1.06% | +1.71% | +119.73% | |
| 34 | PCVX | Vaxcyte Inc | Stock-Other | 0.92% | +0.48% | +131.78% | |
| 35 | SVRA | Savara Inc | Stock-Other | 0.71% | — | — | |
| 36 | PEN | Penumbra Inc | Stock-Healthcare | 0.68% | — | +13.58% | |
| 37 | HUM | Humana Inc | Stock-Healthcare | 0.53% | — | — | |
| 38 | CNC | Centene CORP | Stock-Healthcare | 0.52% | — | — | |
| 39 | EXK | Exact Sciences CORP | Stock-Materials | 0.46% | — | — | |
| 40 | STVN | Stevanato Group S.p.A. | Stock-Other | 0.44% | — | -67.36% | |
| 41 | ASND | Ascendis Pharma A/S | Stock-Other | 0.43% | — | — | |
| 42 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 0.33% | — | -79.90% | |
| 43 | SLP | Simulations Plus Inc | Stock-Other | 0.12% | +0.32% | -1.68% | |
| 44 | ✓ | Stock-Other | 0.03% | — | — |
According to official SEC Form 13F filings, First Light Asset Management, LLC reported a total U.S. public equity portfolio value of $1.6B across 44 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including FNAUSD, ATEC, CRNX) accounted for 16.3% of total reported equity market value during Q2 2024.
During Q2 2024, First Light Asset Management, LLC's top holdings by market value included FNAUSD (4.9%)、ATEC (4.9%)、CRNX (4.7%). The largest single position, FNAUSD, represented 4.9% of total portfolio value.
In Q2 2024, First Light Asset Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.